I

ITF Therapeutics

Develops and commercializes rare-disease therapies

Field Reimbursement Manager

Customer SuccessConfirmed live in the last 24 hours
Full-timeRemote in USA$185k - $215k

About the Job

Requirements

  • A B.S./B.A. degree or higher and 8+ years of experience in the pharmaceutical or biotechnology industry, with expertise in biotech drug distribution across specialty distributors, specialty pharmacies, and hospital systems.
  • Demonstrated understanding of coverage and reimbursement for oral and injectable therapies.
  • Strong expertise in specialty pharmacy operations and third-party services (Patient Support).
  • Deep knowledge of payer/PBM utilization management tactics for new therapies, such as new-to-market blocks and exclusion lists.
  • Extensive understanding of pharmaceutical manufacturer compliance, patient confidentiality, product reimbursement, and product access requirements.
  • Knowledge of regulations and laws governing the protection of patient-identifying information, and relevant laws, regulations, and policies pertaining to access offerings.
  • Extensive knowledge of laws and regulations that govern contracting and pricing for pharmaceutical products.
  • Experience managing long-term enterprise-level relationships, and driving complex contract negotiations and contract pull-through.
  • Deep understanding of and compliance with OIG and FDA regulations governing pharmaceutical marketing and the PhRMA Code.
  • Excellent communication skills with stakeholders at all levels of the organization, and a persuasive and credible presentation style.

Responsibilities

  • Demonstrate deep understanding of reimbursement and access and act as the subject matter expert in the assigned territory.
  • Demonstrate extensive knowledge of individual managed care accounts’ geographic presence and influence, payer mix, product coverage, and reimbursement criteria policies.
  • Educate providers on prior authorization requirements, coverage status, payer appeals requirements, alternate funding options for uninsured and underinsured patients, and associated processes and timelines.
  • Provide access education to healthcare providers and office staff as needed.
  • Serve as a liaison between sales representatives and key external customers.
  • Create and maintain productive relationships with healthcare providers, key stakeholders within healthcare provider offices, and healthcare systems.
  • Use knowledge to assist customers in navigating the complexity of specialty pharmacy distribution.
  • Partner daily with the specialty pharmacy case management team to ensure accurate coverage determinations and optimized processing of enrollments for timely patient access to the product.
  • Partner with the sales team and patient hub/specialty pharmacy to identify accounts experiencing reimbursement issues and specific patients delayed by insurance.
  • Develop and implement solutions for patient access in system-level and individual situations.
  • Perform strategic analyses to develop business plans that identify issues and opportunities.
  • Travel up to approximately 70% to meet customers, attend appropriate conferences, and travel in the field with sales and regional colleagues to call on key providers and influencers.

Desired Qualifications

  • Launch experience, specifically with oral specialty drugs, is highly valued; rare disease experience is a plus.
  • Experience in and understanding of other commercial functions, such as marketing, market access, sales, and insights/analytics, is an important consideration for the role.

About the Company

ITF Therapeutics

Develops and commercializes rare-disease therapies

ITF Therapeutics is a division of Italfarmaco S.p.A. focused on developing and commercializing treatments for rare diseases in the U.S., especially Duchenne Muscular Dystrophy (DMD). The company works on early-stage research and clinical development, partnering with patient advocacy groups and clinical leaders to align programs with patient needs. Its lead program is DUVYZAT (givinostat), a histone deacetylase (HDAC) inhibitor aimed at DMD. Revenue comes from bringing these specialized therapies to market. Compared with competitors, ITF Therapeutics emphasizes collaboration with patient groups and clinicians, a pipeline-focused early-development approach, and a specialty in HDAC inhibitors for rare diseases. The company’s goal is to deliver effective treatments for rare-disease patients by advancing promising therapies through development and into commercialization.

Company size
1-10
Company stage
Not listed
Total funding
Not listed
Headquarters
Concord, NH
Founded
2024

Recently Posted Jobs

Explore more opportunities at ITF Therapeutics

See more jobs